Patents by Inventor Peter H. King

Peter H. King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMYOTROPHIC LATERAL SCLEROSIS (ALS) BIOMARKERS AND USES THEREOF
    Publication number: 20170248579
    Abstract: Provided herein are Amyotrophic lateral sclerosis (ALS) biomarkers and methods of using these ALS biomarkers to diagnose and treat ALS.
    Type: Application
    Filed: September 10, 2015
    Publication date: August 31, 2017
    Applicant: The UAB Research Foundation
    Inventor: Peter H. King
  • Methods and compositions involved in cell growth, neoplasia and immunoregulation
    Patent number: 5698427
    Abstract: A peptide, Hel-N1, which can bind to a 3'-untranslated mRNA sequence (which encompasses the "instability sequence") that is uniquely present in the messenger RNAs that encode oncoproteins and lymphokines, and mediates the specific destruction of the messenger RNAs, is described. Full-length Hel-N1 is capable of suppressing cell growth and causing cellular differentiation. Hel-N1 possess three RNA recognition motifs. One of these forms an RNA-binding domain which, when transfected alone into cells, causes them to undergo rapid growth.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: December 16, 1997
    Assignees: Jack D. Keene, Peter H. King, Todd Levine
    Inventors: Jack D. Keene, Peter H. King, Todd Levine
  • Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation
    Patent number: 5444149
    Abstract: A peptide, Hel-N1 (SEQ ID NO: 2), which can bind to a 3'-untranslated mRNA sequence (which encompasses the "instability sequence") that is uniquely present in the messenger RNAs that encode oncoproteins and lymphokines, and mediates the specific destruction of the messenger RNAs, is described. Full-length Hel-N1 is capable of suppressing cell growth and causing cellular differentiation. Hel-N1 (SEQ ID NO: 2) possess three RNA recognition motifs. One of these forms an RNA-binding domain which, when transfected alone into cells, causes them to undergo rapid growth.
    Type: Grant
    Filed: May 11, 1992
    Date of Patent: August 22, 1995
    Assignee: Duke University
    Inventors: Jack D. Keene, Peter H. King